Skip to main content
. 2022 Jul 13;13:923546. doi: 10.3389/fmicb.2022.923546

TABLE 4.

Pregnancy related complications of SARS-CoV-2 (Goldshtein et al., 2021, 2022; Shimabukuro et al., 2021; Morgan et al., 2022).

SARS-CoV-2 findings
General symptoms
COVID-19 overlap with symptoms of normal pregnancy*
Pregnant people are more likely to be asymptomatic
Common symptoms:
• Cough
• Fever
• Myalgias
• Headache
• Dyspnoea*
• Sore throat
• Diarrhoea
• Nausea/vomiting*
• Anosmia or other smell abnormalities
• Ageusia or other taste abnormalities
• Rhinorrhoea and/or nasal congestion*
• Chills/rigors
• Fatigue*
Pregnancy can worsen the clinical course of SARS-CoV-2, especially in women of older age (especially >35 years), obesity, preexisting medical comorbidities (particularly hypertension, diabetes, or >1 comorbidity), and being unvaccinated.
Consider other viral and bacterial respiratory infections depending on local prevalence.
Laboratory findings:
• Thrombocytopenia
• Elevated liver enzymes
• Autoimmune hemolysis
• Prolonged prothrombin time
• Elevated D-dimer
• Elevated procalcitonin
• Elevated C-reactive protein (CRP) levels
• Positive lupus anticoagulant screen
• Low fibrinogen levels
• Acute kidney injury
Overlap with pregnancy specific conditions Thrombocytopenia elevated liver enzymes Consider preeclampsia, HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome. Symptoms also overlap: Headache, acute cerebrovascular disease, and seizures. Hypertension is a feature of preeclampsia but not usually of SARS-CoV-2.
Acute kidney injury Can also be a severe complication of obstetric disorders, such as pre-eclampsia with severe features, abruptio placentae, or hemorrhagic shock. Uterine bleeding is a prominent feature of the last two disorders but not for SARS- CoV-2 or preeclampsia.
Effects on pregnancy No effect on miscarriage risk
• No effect on risk of congenital anomalies
• Increased in severe disease:
° Preterm birth
° Caesarean section
° Stillbirths
• Increased risk of pre-eclampsia and HELLP syndrome
Vertical transmission Extent of vertical transmission (in utero, intrapartum, early postnatal period) remains unclear, but may occur via hematogenous or ascending route.

The symbol * indicates symptoms that overlap with normal pregnancy changes.